Answers are grounded in this paper and cite their sources.
Background and objective: Polycystic ovary syndrome (PCOS) is a leading cause of infertility and metabolic dysfunction in women of reproductive age. Despite its high prevalence, current medical treatments are largely symptom-targeted and often prescribed off-label, highlighting the need for safer, integrative interventions. Botanical formulations with phytoestrogenic and insulin-sensitizing properties may represent a holistic therapeutic approach. The study aims to evaluate the clinical efficacy and safety of a standardized Asparagus racemosus root extract (CL22209) in women diagnosed with PCOS. Methods: A randomized, double-blind, placebo-controlled clinical trial (registration no: CTRI/2023/11/059457) was conducted in 60 women aged 20–35 years who were diagnosed with PCOS, as determined by the Rotterdam criteria. Participants received either CL22209 (100 mg daily) or a placebo for 84 consecutive days. The primary endpoint was the change in ovarian volume from the baseline. Secondary outcomes included ovarian cyst size and follicle number, menstrual cycle regularity, androgen-related manifestations, anthropometric indices, hormonal parameters, insulin sensitization, and safety. Results: After 84 days of supplementation, CL22209 significantly (P < 0.0001) reduced mean ovarian volume (20.98%), cyst size (40.97%), and follicle number (20.56%) as compared to placebo. The supplement showed exploratory indications of improved insulin sensitivity and hormonal profiles. Modest changes were also seen in menstrual patterns and anthropometric measures. CL22209 was well-tolerated over the study period. Conclusion: CL22209 was well-tolerated and demonstrated broad-spectrum efficacy in women diagnosed with PCOS, improving ovarian morphology, metabolic health, and androgen-mediated symptoms. Future studies with larger sample sizes and longer follow-up durations would help to further validate these findings and clarify CL22209’s role in the management of PCOS.
No takes yet. Share an insight, caveat, or question.
Kondamudi et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: